| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aim Immunotech Inc. (AIM) has 5 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. AIM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.97M | $1.16M | - | |
| Dir | 521.7K | $308.3K | - | |
| COO | 401.8K | $237.4K | - | |
| CEO | 63.9K | $37.8K | - | |
| Dir | 28.4K | $16.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 25, 2018 | Equels Thomas K. | Exec. Vice Chairman/ Ceo/ Pres. | Buy | 100,000 | $0.20 | $20,000.00 | +14.9% | |
| Jul 27, 2018 | Equels Thomas K. | Exec. Vice Chairman/ Ceo/ Pres. | Buy | 34,483 | $0.29 | $10,000.07 | +5.4% | |
| Jul 24, 2018 | Appelrouth Stewart | Director | Buy | 126,000 | $0.31 | $39,060.00 | +108.9% | |
| Jul 23, 2018 | Pascale Adam | CFO | Buy | 32,259 | $0.31 | $10,000.29 | +117.8% | |
| Jul 23, 2018 | Equels Thomas K. | Exec. Vice Chairman/ Ceo/ Pres. | Buy | 112,904 | $0.31 | $35,000.24 | +21.5% | |
| Jul 23, 2018 | Springate Wayne S | Sr. VP Of Operations | Buy | 32,259 | $0.31 | $10,000.29 | +99.2% | |
| Apr 27, 2018 | Equels Thomas K. | CEO, President | Buy | 32,000 | $0.32 | $10,240.00 | +6.5% | |
| Apr 27, 2018 | Appelrouth Stewart | Director | Buy | 100,000 | $0.32 | $32,000.00 | +634.9% | |
| May 2, 2017 | Rodino Peter W. III | Exec Dir Govt Relations/ Secrty | Buy | 15,873 | $0.63 | $9,999.99 | New | |
| May 2, 2017 | Springate Wayne S. | Sr VP Of Operations | Buy | 15,873 | $0.63 | $9,999.99 | +95.4% |